XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,419,416 | -11.3% | 100,100 | 0.0% | 0.01% | -9.1% |
| Q2 2023 | $3,853,850 | +47.5% | 100,100 | +37.1% | 0.01% | +37.5% |
| Q1 2023 | $2,612,670 | +39.8% | 73,000 | +54.0% | 0.01% | +33.3% |
| Q4 2022 | $1,868,982 | +88.2% | 47,400 | +72.4% | 0.01% | +100.0% |
| Q3 2022 | $993,000 | +48.4% | 27,500 | +25.0% | 0.00% | +50.0% |
| Q2 2022 | $669,000 | -47.9% | 22,000 | -47.6% | 0.00% | -33.3% |
| Q1 2022 | $1,284,000 | -2.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,312,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |